• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Overview of the Updated AASLD Guidelines for the Management of HCC.美国肝病研究学会（AASLD）更新版肝细胞癌管理指南概述
Gastroenterol Hepatol (N Y). 2017 Dec;13(12):751-753.
2
Current guidelines for chemoembolization for hepatocellular carcinoma: Room for improvement?肝细胞癌化疗栓塞的现行指南：有改进空间吗？
Hepatol Commun. 2017 May 18;1(4):338-346. doi: 10.1002/hep4.1046. eCollection 2017 Jun.
3
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.2010 年 AASLD 肝癌诊断指南的临床和经济影响。
J Hepatol. 2014 May;60(5):995-1001. doi: 10.1016/j.jhep.2014.01.006. Epub 2014 Jan 22.
4
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.遵循美国肝病研究协会2018年肝细胞癌管理指南及其对生存的影响。
J Cancer Res Ther. 2023 Jul-Sep;19(5):1103-1108. doi: 10.4103/jcrt.jcrt_1861_20.
5
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.《2019年中国肝细胞癌管理临床指南：更新与见解》
Hepatobiliary Surg Nutr. 2020 Aug;9(4):452-463. doi: 10.21037/hbsn-20-480.
6
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.小肝细胞癌（HCC）在超声造影（CEUS）、多排螺旋 CT（MDCT）和 MRI 中的增强模式：2005 年和 2010 年美国肝病研究协会（AASLD）指南之间的多模态一致性和诊断灵敏度比较。
Eur J Radiol. 2012 Sep;81(9):2099-105. doi: 10.1016/j.ejrad.2011.07.010. Epub 2011 Sep 8.
7
Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.肝细胞癌的无创性诊断标准：LI-RADS 更新版与 OPTN-UNOS、AASLD、NCCN、EASL-EORTC 和 KLSCG-NCC 临床实践指南的诊断准确性比较。
PLoS One. 2019 Dec 10;14(12):e0226291. doi: 10.1371/journal.pone.0226291. eCollection 2019.
8
Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.移植候选者使用钆塞酸增强 MRI 诊断肝细胞癌的指南比较。
Eur Radiol. 2020 Sep;30(9):4762-4771. doi: 10.1007/s00330-020-06881-y. Epub 2020 Apr 25.
9
Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.对高危患者应用钆塞酸增强 MRI 进行肝细胞癌诊断的现行指南的回顾性分析。
Eur Radiol. 2021 Jul;31(7):4751-4763. doi: 10.1007/s00330-020-07577-z. Epub 2021 Jan 3.
10
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.日本肝细胞癌的管理：日本肝脏学会（JSH）2010 年更新版提出的基于共识的临床实践指南。
Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.

引用本文的文献

1
Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: protocol for a large cluster-randomized implementation study.比较改善退伍军人肝癌和结肠癌筛查实施策略的有效性：一项大型整群随机实施研究的方案
Implement Sci. 2025 Aug 9;20(1):38. doi: 10.1186/s13012-025-01448-1.
2
Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.与退伍军人健康管理局肝硬化治疗相关的组织和实施因素。
Dig Dis Sci. 2024 Jun;69(6):2008-2017. doi: 10.1007/s10620-024-08409-6. Epub 2024 Apr 14.
3
Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.2021 年肝细胞癌的诊断与管理：一项国家退伍军人事务部质量改进项目。
Clin Gastroenterol Hepatol. 2024 Feb;22(2):324-338. doi: 10.1016/j.cgh.2023.07.002. Epub 2023 Jul 15.
4
Delayed referral for liver transplant evaluation worsens outcomes in chronic liver disease patients requiring inpatient transplant evaluation.对于需要住院进行肝移植评估的慢性肝病患者，延迟进行肝移植评估会使结局恶化。
World J Transplant. 2023 Jun 18;13(4):169-182. doi: 10.5500/wjt.v13.i4.169.
5
Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy.非手术复发性肝细胞癌的放射学表现：从局部区域治疗到免疫治疗。
World J Gastroenterol. 2023 Mar 21;29(11):1669-1684. doi: 10.3748/wjg.v29.i11.1669.
6
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.更新血液生物标志物及其算法在肝细胞癌诊断和监测中的临床应用：批判性评价。
Int J Mol Sci. 2023 Feb 21;24(5):4286. doi: 10.3390/ijms24054286.
7
Core implementation strategies for improving cirrhosis care in the Veterans Health Administration.改善退伍军人健康管理局肝硬化护理的核心实施策略。
Hepatology. 2022 Aug;76(2):404-417. doi: 10.1002/hep.32395. Epub 2022 Mar 17.
8
Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome.比较直接作用抗病毒治疗丙型肝炎前后的肝活检结果，并与临床结果相关。
Sci Rep. 2021 Jul 15;11(1):14506. doi: 10.1038/s41598-021-93881-7.
9
Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience.与经皮肝活检相比，内镜超声引导下肝活检的诊断率：一项两中心经验
Cancers (Basel). 2021 Jun 19;13(12):3062. doi: 10.3390/cancers13123062.
10
Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.一线系统治疗晚期肝细胞癌的选择：一项随机对照试验的网络荟萃分析。
World J Gastroenterol. 2021 May 21;27(19):2415-2433. doi: 10.3748/wjg.v27.i19.2415.

本文引用的文献

1
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.
2
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.根据EASL标准和mRECIST标准评估局部区域治疗的肝细胞癌患者客观缓解的预后相关性：一项基于文献的荟萃分析
PLoS One. 2015 Jul 31;10(7):e0133488. doi: 10.1371/journal.pone.0133488. eCollection 2015.
3
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.降低肝细胞癌分期：一项系统评价与汇总分析
Liver Transpl. 2015 Sep;21(9):1142-52. doi: 10.1002/lt.24169.
4
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.肝硬化患者肝细胞癌监测的早期检测、治愈治疗和生存率：一项荟萃分析。
PLoS Med. 2014 Apr 1;11(4):e1001624. doi: 10.1371/journal.pmed.1001624. eCollection 2014 Apr.
5
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.索拉非尼治疗晚期肝细胞癌患者的疗效和安全性：III 期临床试验的亚组分析。
J Hepatol. 2012 Oct;57(4):821-9. doi: 10.1016/j.jhep.2012.06.014. Epub 2012 Jun 19.
6
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.肝癌肝移植治疗的推荐：国际共识会议报告。
Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31.

Overview of the Updated AASLD Guidelines for the Management of HCC.

作者信息

Heimbach Julie K

机构信息

Professor of Surgery Mayo Clinic Rochester, Minnesota.

出版信息

Gastroenterol Hepatol (N Y). 2017 Dec;13(12):751-753.

PMID:29339953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5763563/
Abstract
摘要